AAMMF
Almadex Minerals Ltd.
OTC Markets OTCPKUSDEQUITY
Basic Materials
DELAYED
Last price
0.35
■ 0.00 (0.00%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
0.35
Prev close
0.35
Day high
0.40
Day low
0.40
Volume
100
Market cap
$21.46M
P/E (TTM)
35.00
52W range
0.25 – 0.58
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
3.83M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Oct 15, 25 | Meintjes (Tracey) Director of Issuer |
SELL | 20.00K | $8.12K | Direct |
| Oct 14, 25 | Meintjes (Tracey) Director of Issuer |
SELL | 20.00K | $7.84K | Direct |
| Oct 3, 25 | Meintjes (Tracey) Director of Issuer |
SELL | 25.00K | $10.57K | Direct |
| Sep 17, 25 | Meintjes (Tracey) Director of Issuer |
EXERCISE | 174.17K | $82.21K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Meintjes (Tracey) |
Director of Issuer | 109.17K | Acquisition or disposition in the public market |
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
+1.45%
+2.8%
1M
+25.00%
+21.3%
3M
+6.06%
+3.0%
6M
-23.91%
-35.0%
YTD
0.00%
-12.3%
1Y
+10.97%
-9.0%
3Y
+98.03%
+23.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$21.46M
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)$0.01
Free cash flow—
Total cash—
Total debt—
Book value / share$0.34
Shares outstanding61.31M
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E35.00
Forward P/E—
PEG ratio—
Price / sales—
Price / book1.03
EV / revenue—
EV / EBITDA—
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $772.97K | $44.95K | $647.51K | $6.93M | +1,619.8% |
| Operating revenue | $772.97K | $44.95K | $647.51K | $6.93M | +1,619.8% |
| Cost of revenue | $504.96K | $163.50K | $349.82K | $917.37K | +208.8% |
| Gross profit | $268.01K | -$118.55K | $297.69K | $6.01M | +326.1% |
| Selling, general & admin | $2.21M | $1.58M | $2.90M | $3.45M | +40.2% |
| Total operating expense | $2.65M | $2.12M | $3.52M | $3.66M | +25.2% |
| Operating income | -$2.38M | -$2.23M | -$3.22M | $2.35M | -6.6% |
| Net interest income | $496.87K | $999.14K | $973.06K | $529.96K | -50.3% |
| Pre-tax income | $785.10K | $1.82M | -$2.97M | $3.42M | -56.9% |
| Tax provision | -$21.11K | -$181.37K | -$24.59K | $199.16K | +88.4% |
| Net income | $806.21K | $2.00M | -$2.94M | $3.22M | -59.7% |
| Net income to common | $806.21K | $2.00M | -$2.94M | $3.22M | -59.7% |
| Basic EPS | 0.01 | 0.03 | -0.05 | 0.06 | -66.7% |
| Diluted EPS | 0.01 | 0.03 | -0.05 | 0.06 | -66.7% |
| EBIT | -$2.38M | -$2.23M | -$3.22M | $2.35M | -6.6% |
| EBITDA | -$2.26M | -$2.07M | -$2.96M | $2.58M | -9.2% |
| Basic shares | 61.06M | 61.01M | 60.90M | 60.61M | +0.1% |
| Diluted shares | 62.11M | 61.01M | 60.90M | 60.98M | +1.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $7.53M | $12.89M | $16.22M | $18.40M | -41.6% |
| Cash & short-term investments | $20.07M | $13.94M | $17.32M | $19.48M | +44.1% |
| Accounts receivable | $165.82K | $160.82K | $121.09K | $561.84K | +3.1% |
| Total current assets | $20.40M | $14.17M | $17.48M | $20.14M | +44.0% |
| Property, plant & equipment | $8.50M | $5.38M | $3.00M | $2.99M | +58.0% |
| Total assets | $29.13M | $28.20M | $26.39M | $28.44M | +3.3% |
| Total current liabilities | $444.41K | $395.42K | $590.34K | $443.57K | +12.4% |
| Total liabilities | $444.41K | $395.42K | $590.34K | $443.57K | +12.4% |
| Retained earnings | $2.58M | $1.77M | -$230.73K | $2.71M | +45.5% |
| Shareholder equity | $28.69M | $27.80M | $25.80M | $28.00M | +3.2% |
| Working capital | $19.95M | $13.77M | $16.89M | $19.69M | +44.9% |
| Net tangible assets | $28.69M | $27.80M | $25.80M | $28.00M | +3.2% |
| Shares issued | 61.18M | 61.01M | 61.01M | 60.70M | +0.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $806.21K | $2.00M | -$2.94M | $3.22M | -59.7% |
| Depreciation & amortisation | $120.36K | $163.50K | $257.32K | $228.00K | -26.4% |
| Stock-based compensation | $120.80K | $1.75K | $788.27K | $56.00K | +6,802.9% |
| Change in working capital | $152.70K | -$42.85K | $832.85K | -$607.51K | +456.4% |
| Operating cash flow | -$2.11M | -$360.48K | -$873.50K | $3.36M | -486.2% |
| Capital expenditure | -$35.41K | -$108.21K | -$7.08K | -$452.22K | +67.3% |
| Investing cash flow | -$3.21M | -$2.97M | -$1.26M | -$2.17M | -7.9% |
| Financing cash flow | -$40.79K | $0 | -$41.75K | -$10.13K | — |
| Free cash flow | -$2.15M | -$468.69K | -$880.59K | $2.91M | -358.4% |
| End cash position | $7.53M | $12.89M | $16.22M | $18.40M | -41.6% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $46.46K | $594.18K | $131.10K | $0 | $47.69K | — | -92.2% |
| Operating revenue | $46.46K | $594.18K | $131.10K | $0 | $47.69K | — | -92.2% |
| Cost of revenue | $164.30K | $338.99K | $103.29K | $31.87K | $30.80K | — | -51.5% |
| Gross profit | -$117.84K | $255.19K | $27.81K | -$31.87K | $16.89K | — | -146.2% |
| Selling, general & admin | $375.75K | $817.34K | $608.47K | $406.02K | $379.70K | — | -54.0% |
| Total operating expense | $580.59K | $919.86K | $671.95K | $524.15K | $533.79K | — | -36.9% |
| Operating income | -$698.43K | -$664.67K | -$644.14K | -$556.02K | -$516.91K | — | -5.1% |
| Net interest income | $40.08K | $95.24K | $111.08K | $132.10K | $158.44K | — | -57.9% |
| Pre-tax income | $870.22K | $596.91K | $1.21M | -$1.65M | $626.41K | — | +45.8% |
| Tax provision | — | $160.27K | -$181.37K | — | — | $20.01K | — |
| Net income | $870.22K | $436.64K | $1.39M | -$1.65M | $626.41K | — | +99.3% |
| Net income to common | $870.22K | $436.64K | $1.39M | -$1.65M | $626.41K | — | +99.3% |
| Basic EPS | 0.01 | — | 0.02 | -0.03 | 0.01 | — | — |
| Diluted EPS | 0.01 | — | 0.02 | -0.03 | 0.01 | — | — |
| EBIT | -$698.43K | -$664.67K | -$644.14K | -$556.02K | -$516.91K | — | -5.1% |
| EBITDA | -$667.86K | -$636.25K | -$614.88K | -$524.15K | -$486.11K | — | -5.0% |
| Basic shares | 61.24M | — | 61.03M | 61.01M | 61.01M | — | — |
| Diluted shares | 61.24M | — | 61.59M | 61.01M | 61.01M | — | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $8.39M | $7.53M | $8.62M | $10.28M | $12.24M | +11.3% |
| Cash & short-term investments | $19.72M | $20.07M | $19.94M | $11.14M | $13.11M | -1.8% |
| Accounts receivable | $233.22K | $165.82K | $166.64K | $49.31K | $29.22K | +40.6% |
| Total current assets | $20.06M | $20.40M | $20.26M | $11.30M | $13.18M | -1.7% |
| Property, plant & equipment | $9.62M | $8.50M | $7.76M | $6.42M | $5.69M | +13.2% |
| Total assets | $29.90M | $29.13M | $28.49M | $27.07M | $28.78M | +2.6% |
| Total current liabilities | $342.64K | $444.41K | $321.79K | $253.65K | $356.57K | -22.9% |
| Total liabilities | $342.64K | $444.41K | $321.79K | $253.65K | $356.57K | -22.9% |
| Retained earnings | $3.45M | $2.58M | $2.14M | $750.85K | $2.40M | +33.8% |
| Shareholder equity | $29.56M | $28.69M | $28.17M | $26.81M | $28.43M | +3.0% |
| Working capital | $19.71M | $19.95M | $19.94M | $11.05M | $12.83M | -1.2% |
| Net tangible assets | $29.56M | $28.69M | $28.17M | $26.81M | $28.43M | +3.0% |
| Shares issued | 61.31M | 61.18M | 61.18M | 61.01M | 61.01M | +0.2% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $870.22K | $436.64K | $1.39M | -$1.65M | $626.41K | — | +99.3% |
| Depreciation & amortisation | $30.57K | $28.42K | $29.27K | $31.87K | $30.80K | — | +7.6% |
| Stock-based compensation | — | $80.50K | $7.50K | $32.80K | — | $0 | — |
| Change in working capital | -$171.26K | $302.57K | -$67.56K | -$148.81K | $66.51K | — | -156.6% |
| Operating cash flow | -$714.05K | -$452.83K | -$194.10K | -$1.12M | -$342.90K | — | -57.7% |
| Capital expenditure | -$255.30K | -$9.70K | — | — | -$25.71K | -$57.81K | -2,532.8% |
| Investing cash flow | $1.57M | -$630.66K | -$1.43M | -$837.49K | -$308.01K | — | +348.5% |
| Financing cash flow | $0 | $0 | -$40.79K | $0 | $0 | — | — |
| Free cash flow | -$969.36K | -$462.52K | -$194.10K | -$1.12M | -$368.61K | — | -109.6% |
| End cash position | $8.39M | $7.53M | $8.62M | $10.28M | $12.24M | — | +11.3% |
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders6.25%
Held by institutions15.02%
Institutions holding2
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.35
-0.37% from price
SMA 20
0.32
+8.88% from price
SMA 50
0.30
+16.47% from price
SMA 100
0.33
+6.38% from price
SMA 200
0.37
-4.74% from price
EMA 12
0.34
+2.28% from price
EMA 26
0.32
+7.86% from price
EMA 50
0.32
+9.70% from price
RSI (14)
56.0
Neutral
MACD (12,26,9)
0.02
Hist 0.00
ATR (14)
0.03
7.41% of price
Realised vol 30D
157.3%
Annualised
Bollinger upper
0.40
20, 2σ
Bollinger lower
0.25
20, 2σ
50 / 200 cross
Death
0.30 vs 0.37
Trend bias
Below 200
-4.74%
Risk profile
Beta vs SPY
0.70
Less volatile than market
Correlation to SPY
0.06
Largely independent
Realised vol 30D
157.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-56.1%
Peak to trough
Max drawdown 5Y
-87.8%
Peak to trough
ATR 14
0.03
7.41% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Almaden Minerals Says Arbitration Hearing Dates Delayed to July 2027
MT Newswires · 8d ago
Almaden Provides Update on Arbitration Process with Mexico
GlobeNewswire · 9d ago
Almadex Announces Completion of Sale of Royalty Interests
GlobeNewswire · 17d ago
Empress Announces Closing of Acquisition of North American Royalty Portfolio
ACCESS Newswire · 17d ago
Almadex Minerals Selling Royalty Interests to Empress Royalty For $2.5 Million
MT Newswires · 43d ago
Almadex Announces Sale of Royalty Interests
GlobeNewswire · 43d ago
Empress Announces Acquisition of North American Royalty Portfolio
ACCESS Newswire · 43d ago
Almadex Intersects Copper Mineralisation, Expands IP Anomaly at New Hope And Provides Exploration Update
GlobeNewswire · 53d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.